StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aristotle appointments gone for this week

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Jan 26, 2022 9:59pm

119 Views

Post# 34365262

RE:RE:RE:RE:Aristotle appointments gone for this week

This is how the company thinks i bet.

2 case managers taking X number of "appointments" a day = X amount of tests.

But the X amount of tests is a pathetically low number so how do they get that number up?

spend more money hiring case managers to try and get that aristotle test number up at all cost

this is all just another BS covid test spreadsheet. you investors left guessing at what is going on. Was anyone except the serial basher correct? Anyone?

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland